Back to Search
DANIEL HENDERSON, MD
MD
Internal Medicine Physician
NPI: 1831457811IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
263575(MA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE
Class of 2012
Research & Publications (20)
Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.
PMID 19512978·J Clin Psychopharmacol·2009
2-rct
Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine.
PMID 19625881·J Psychiatr Pract·2009
8-other
Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia.
PMID 19283774·Hum Psychopharmacol·2009
3-trial
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia.
PMID 19183127·Acta Psychiatr Scand·2009
4-observational
Managing weight gain and metabolic issues in patients treated with atypical antipsychotics.
PMID 18363448·J Clin Psychiatry·2008
6-review
Prolactin-related and metabolic adverse effects of atypical antipsychotic agents.
PMID 18484806·J Clin Psychiatry·2008
5-case
Considerations for inpatient versus outpatient treatment with antipsychotics.
PMID 18389922·CNS Spectr·2007
4-observational
Weight gain with atypical antipsychotics: evidence and insights.
PMID 17956152·J Clin Psychiatry·2007
6-review
Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.
PMID 17474808·J Clin Psychiatry·2007
8-other
A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain.
PMID 17244173·Acta Psychiatr Scand·2007
2-rct
Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
PMID 16841629·J Clin Psychiatry·2006
4-observational
An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia.
PMID 16423166·Acta Psychiatr Scand·2006
3-trial
Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophrenia.
PMID 16423163·Acta Psychiatr Scand·2006
8-other
Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.
PMID 16187768·J Clin Psychiatry·2005
4-observational
Building primary care practitioners' attitudes and confidence in mental health skills in a post-conflict society: a Cambodian example.
PMID 16082300·J Nerv Ment Dis·2005
4-observational
A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.
PMID 15863798·Am J Psychiatry·2005
3-trial
Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
PMID 15630069·Arch Gen Psychiatry·2005
4-observational
Clozapine and hypertension: a chart review of 82 patients.
PMID 15163256·J Clin Psychiatry·2004
4-observational
Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.
PMID 12643133·Curr Diab Rep·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 5 locations total
- Address
- 15 PARKMAN ST, WANG CENTER, 6TH FLOOR
BOSTON, MA 02114 - Phone
- (617) 724-6670
Quick Facts
- NPI
- 1831457811
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 5
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile